Shetzline Michael's Form 4 filing
Ironwood Pharmaceuticals Inc (IRWD) · filed Feb 12, 2025
- Accession no.
- 0000950170-25-019235
- Filed
- Feb 12, 2025
- Trade date
- Feb 10, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $72.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Shetzline MichaelCIK 0001808509 | Officer (SVP, CMO, Head-Res&Drug) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 10, 2025 | Class A Common Stock | AGrant or awardAcquired | +133,333 | $0.00 | $0 | 595,276 | Direct | |
| Feb 10, 2025 | Class A Common Stock | SSaleDisposed | −41,269 | $1.76 | −$72,633.44 | 554,007 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.